Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$372.46+1.98 (+0.53%)
Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%
Labcorp total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Labcorp's total debt was $5.85B at Sep 30, 2026. For fiscal 2025 it was $5.58B, down 11.8% from the year before. Over ten years it grew -1.3% a year on average. The highest annual figure on record is $6.76B in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.58B | -11.8% |
| FY2024 | Dec 31, 2024 | $6.33B | +25.3% |
| FY2023 | Dec 31, 2023 | $5.05B | -5.3% |
| FY2022 | Dec 31, 2022 | $5.34B | -1.4% |
| FY2021 | Dec 31, 2021 | $5.42B | -6.5% |
| FY2020 | Dec 31, 2020 | $5.80B | -6.6% |
| FY2019 | Dec 31, 2019 | $6.21B | +3.4% |
| FY2018 | Dec 31, 2018 | $6.00B | -11.3% |
| FY2017 | Dec 31, 2017 | $6.76B | +15.6% |
| FY2016 | Dec 31, 2016 | $5.85B | -8.1% |
| FY2015 | Dec 31, 2015 | $6.36B | +110.1% |
| FY2014 | Dec 31, 2014 | $3.03B | +1.0% |
| FY2013 | Dec 31, 2013 | $3.00B | +13.0% |
| FY2012 | Dec 31, 2012 | $2.66B | +19.5% |
| FY2011 | Dec 31, 2011 | $2.22B | +1.5% |
| FY2010 | Dec 31, 2010 | $2.19B | +56.9% |
| FY2009 | Dec 31, 2009 | $1.39B | -19.0% |
| FY2008 | Dec 31, 2008 | $1.72B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.85B | +15.1% |
| Q2 FY2026 | Jun 30, 2026 | $5.86B | +15.4% |
| Q1 FY2026 | Mar 31, 2026 | $6.33B | +13.7% |
| Q4 FY2025 | Dec 31, 2025 | $5.58B | -11.8% |
| Q3 FY2025 | Sep 30, 2025 | $5.08B | -5.0% |
| Q2 FY2025 | Jun 30, 2025 | $5.08B | +66.6% |
| Q1 FY2025 | Mar 31, 2025 | $5.57B | +82.7% |
| Q4 FY2024 | Dec 31, 2024 | $6.33B | +25.3% |
| Q3 FY2024 | Sep 30, 2024 | $5.35B | +20.9% |
| Q2 FY2024 | Jun 30, 2024 | $3.05B | -39.6% |
| Q1 FY2024 | Mar 31, 2024 | $3.05B | -39.7% |
| Q4 FY2023 | Dec 31, 2023 | $5.05B | -5.3% |
| Q3 FY2023 | Sep 30, 2023 | $4.43B | -17.0% |
| Q2 FY2023 | Jun 30, 2023 | $5.04B | -5.9% |
| Q1 FY2023 | Mar 31, 2023 | $5.05B | -6.1% |
| Q4 FY2022 | Dec 31, 2022 | $5.34B | -1.4% |
| Q3 FY2022 | Sep 30, 2022 | $5.33B | -1.5% |
| Q2 FY2022 | Jun 30, 2022 | $5.36B | -1.1% |
| Q1 FY2022 | Mar 31, 2022 | $5.38B | +9.4% |
| Q4 FY2021 | Dec 31, 2021 | $5.42B | -6.5% |
| Q3 FY2021 | Sep 30, 2021 | $5.42B | -6.5% |
| Q2 FY2021 | Jun 30, 2021 | $5.42B | -12.6% |
| Q1 FY2021 | Mar 31, 2021 | $4.92B | -20.7% |
| Q4 FY2020 | Dec 31, 2020 | $5.80B | -6.6% |
| Q3 FY2020 | Sep 30, 2020 | $5.79B | -12.3% |
| Q2 FY2020 | Jun 30, 2020 | $6.21B | -6.5% |
| Q1 FY2020 | Mar 31, 2020 | $6.21B | +3.5% |
| Q4 FY2019 | Dec 31, 2019 | $6.21B | +3.4% |
| Q3 FY2019 | Sep 30, 2019 | $6.60B | +2.2% |
| Q2 FY2019 | Jun 30, 2019 | $6.64B | +2.8% |
| Q1 FY2019 | Mar 31, 2019 | $6.00B | -11.5% |
| Q4 FY2018 | Dec 31, 2018 | $6.00B | -11.3% |
| Q3 FY2018 | Sep 30, 2018 | $6.46B | -10.5% |
| Q2 FY2018 | Jun 30, 2018 | $6.46B | +5.4% |
| Q1 FY2018 | Mar 31, 2018 | $6.78B | +14.5% |
| Q4 FY2017 | Dec 31, 2017 | $6.76B | +15.6% |
| Q3 FY2017 | Sep 30, 2017 | $7.22B | – |
| Q2 FY2017 | Jun 30, 2017 | $6.13B | – |
| Q1 FY2017 | Mar 31, 2017 | $5.92B | – |
| Q4 FY2016 | Dec 31, 2016 | $5.85B | – |
See a number that looks wrong?